Group newsletter: CCTG Connection

Archived Bulletins

August 21, 2019

Published: August 21, 2019
Category: Group updates
Senior Investigator in the Investigational New Drug (IND) Program

The Canadian Cancer Trials Group is seeking a Physician trained in a cancer-related specialty to join our research group as a Senior Investigator in the Investigational New Drug (IND) Program.

Read More

Published: August 21, 2019
Category: News

It is with great sadness that CCTG shares the news of the passing of Aldo Del Col, a valued member of the CCTG Patient Representative Committee and the Hematology Disease Site Committee. He worked tirelessly to ensure that the patient voice was part of the design and conduct of CCTG clinical trials.

Read More

Published: August 21, 2019
Category: News

Dr. Michael McKenzie is a radiation oncologist with extensive experience in genitourinary oncology, neurooncology and palliative oncology at the BC Cancer Agency (BCCA), Vancouver Cancer Centre, and a Clinical Professor in the Division of Radiation Oncology and Developmental Radiotherapeutics at University of British Columbia. He works with patients with genitourinary cancers and brain tumours. He has served as Chair of BCCA’s Palliative Care Network. 

Read More

August 07, 2019

Published: August 07, 2019
Category: Group updates

The Pharmacist Network is actively seeking a volunteer as Pharmacist Representative for the Lung Disease Site Committee.

The Pharmacist Disease Site Committee representative is expected to represent the perspective of the Pharmacist community during discussion of potential new studies and ongoing trials.  Please review terms of reference at: Pharmacist Representatives on Disease Site Committees

Read More

Published: August 07, 2019
Category: Group updates
CCTG Head and Neck Executive Committee is seeking members

The Canadian Cancer Trials Group's (CCTG) Head and Neck Executive Committee (HNEC) is currently seeking individuals with interest and experience in head and neck studies to join the HNEC. In broad terms (adapted from the CCTG's Terms of Reference), the roles of the Disease Site Committee (DSC) Executive members are to:

Read More

Published: August 07, 2019
Category: Group updates

The Frances A Shepherd Award will be disbursed to one to two investigators or post-graduate trainees, traveling to present CCTG related work at major international meetings where the material has been accepted for presentation. Each award will be $1000 and offered twice a year. Applicants who have had their research accepted for oral or poster presentation at an international scientific meeting and have not received another award to support their travel are eligible to apply.

Each applicant must submit:

Read More

Published: August 07, 2019
Category: Publications

Three new publications from the CCTG Committee on Economic Analysis

  1. Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
  2. The economic impact of the transition from branded to generic oncology drugs
  3. CAR T-cells: costs, comparisons, and commentary
Read More

July 24, 2019

Published: July 24, 2019
Category: Trials

BRC7 trial has been centrally activated, this is a Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Post Progression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker Signature-driven Analysis

Activation Date: July 10, 2019 NCT Registration ID: NCT03793179

Read More